Taub Foundation Grants Program for MDS Research
The Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative translational research to understand the underlying causes of MDS and to advance its treatment and prevention. The Program specifically focuses on MDS research, exclusive of AML and MPN. Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged.
Three-year awards of $600,000 ($200,000 per year, inclusive of 10% indirect costs) will be made to independent investigators working in non-profit, non-governmental academic, medical, or research institutions within the United States. Collaborative efforts are encouraged.
The Program is a two-step proposal process. Applicants submit an Initial Proposal by the designated deadline. Selected applicants will be invited for Full Proposals, due in mid-August. Funding begins on November 1, 2015.
Please download the Initial Proposal Guidelines and Application Instructions (right) for further information.
Use the following links to access the Initial Online Application:
Begin a New Online Application:
Return to a Saved Online Application:
Sign up for our email list to receive funding announcements for the Taub Foundation Grants Program for MDS Research.